These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1564164)

  • 1. Vasculitis occurring after intravenous anistreplase.
    Burrows N; Jones RR
    J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):508. PubMed ID: 1564164
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholesterol embolism after intravenous anisoylated plasminogen streptokinase activator complex (APSAC).
    Beutler JJ; Sulzer MA; van Stralen R
    Neth J Med; 1991 Dec; 39(5-6):373-4. PubMed ID: 1803250
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of results of intravenous infusion of anistreplase versus streptokinase in acute myocardial infarction.
    Vogt P; Monnier P; Schaller MD; Goy JJ; Beuret P; Essinger A; Bachmann F; Hauert J; Perret C; Sigwart U
    Am J Cardiol; 1993 Feb; 71(4):274-80. PubMed ID: 8427167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anistreplase for acute M.I.
    Blake GJ
    Nursing; 1990 Oct; 20(10):113. PubMed ID: 2216077
    [No Abstract]   [Full Text] [Related]  

  • 5. Rash after treatment with anistreplase.
    Burrows N; Jones RR
    Br Heart J; 1990 Oct; 64(4):289-90. PubMed ID: 2223309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the pharmacokinetic properties of streptokinase and anistreplase in acute myocardial infarction.
    Gemmill JD; Hogg KJ; Burns JM; Rae AP; Dunn FG; Fears R; Ferres H; Standring R; Greenwood H; Pierce D
    Br J Clin Pharmacol; 1991 Feb; 31(2):143-7. PubMed ID: 2049230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasculitis complicating treatment with intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Bucknall C; Darley C; Flax J; Vincent R; Chamberlain D
    Br Heart J; 1988 Jan; 59(1):9-11. PubMed ID: 2963655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive reperfusion study. II. Multicentre European randomized trial of anistreplase vs streptokinase in acute myocardial infarction.
    Pacouret G; Charbonnier B; Curien ND; Monassier JP; Cribier A; Materne P; Brochier ML; Letac R; Hanssen M; Sacrez A
    Eur Heart J; 1991 Feb; 12(2):179-85. PubMed ID: 2044551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasculitis complicating treatment with intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Gemmill JD; Sandler M; Hillis WS; Tillman J; Wakeel R
    Br Heart J; 1988 Oct; 60(4):361. PubMed ID: 3056478
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cholesterol crystal embolization after intravenous thrombolysis by anistreplase for suspected myocardial infarction].
    Coppere B; Granade G; Girard-Madoux MH; Claudel JP; Kruszynski G; Porte J; Gayral M; Ninet J
    Presse Med; 1992 Dec; 21(42):2061. PubMed ID: 1294983
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypersensitivity vasculitis after thrombolytic therapy with APSAC (anisoylated plasminogen streptokinase activator complex). Presentation of a clinical case and review of the literature].
    Gianni R; Benucci M; Santoro E; Nenci G; Baruffi MC; Cappelletti C
    Ann Ital Med Int; 1994; 9(2):105-6. PubMed ID: 7917762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low back pain associated with anistreplase.
    Lear J; Rajapakse R
    BMJ; 1993 Apr; 306(6882):896. PubMed ID: 8490418
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse reactions with anistreplase.
    Brenot F; Pacouret G; Meyer G; Sors H; Charbonnier B; Simonneau G
    Lancet; 1991 Jul; 338(8759):114-5. PubMed ID: 1676440
    [No Abstract]   [Full Text] [Related]  

  • 14. Guillain-Barré syndrome after acute myocardial infarction treated with anistreplase.
    Ancillo P; Duarte J; Cortina JJ; Sempere AP; Clavería LE
    Chest; 1994 Apr; 105(4):1301-2. PubMed ID: 8162787
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
    Cannon CP; McCabe CH; Diver DJ; Herson S; Greene RM; Shah PK; Sequeira RF; Leya F; Kirshenbaum JM; Magorien RD
    J Am Coll Cardiol; 1994 Dec; 24(7):1602-10. PubMed ID: 7963104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-term comparative study of anistreplase versus streptokinase in acute myocardial infarction.
    Silber H; Hausmann MJ; Katz A; Gilutz H; Zucker N; Ovsyshcher I
    Angiology; 1992 Jul; 43(7):572-7. PubMed ID: 1626735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary artery thrombolysis: comparison of approved agents.
    Porter RS; DiPalma JR
    Am Fam Physician; 1991 Aug; 44(2):591-8. PubMed ID: 1907085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis following anistreplase-induced fibrinolysis in the acute phase of myocardial infarction].
    Dubettier S; Vial T; Falque B; Finet G; Lagable M; Milon H; Evreux JC
    Presse Med; 1991 Mar; 20(9):427-8. PubMed ID: 1826780
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous bolus application of streptokinase and of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Clinical and haemostaseological findings.
    Hellstern P; Doenecke P; Köhler M; Schwerdt H; Ozbek C; Miyashita C; Bette L; Wenzel E
    Drugs; 1987; 33 Suppl 3():183-5. PubMed ID: 3315589
    [No Abstract]   [Full Text] [Related]  

  • 20. Raised levels of antistreptokinase antibody and neutralization titres from 4 days to 54 months after administration of streptokinase or anistreplase.
    Lee HS; Cross S; Davidson R; Reid T; Jennings K
    Eur Heart J; 1993 Jan; 14(1):84-9. PubMed ID: 8432298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.